Cardiometabolic Devices Accuracy Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 359 participants.
Also called NCT05257564
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 359 participants
- Sponsor
- Registry
-
NCT05257564
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Nepal
- Registry status
- Completed
Technical summary
Registry record NCT05257564. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-02-14 (actual); primary completion 2022-05-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiometabolic Devices Accuracy Study
- Condition
- Diabetes Mellitus
- Condition
- Chronic Kidney Diseases
- Condition
- Hyperlipidemias
- Intervention (Device)
- Determine the accuracy of quantitative measurements of GLU, HbA1c (A1C),CHOL and CRE with POC devices compared to a laboratory reference method (Roche)
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Collaborator
- University Hospital, Geneva
- Collaborator
- B.P. Koirala Institute of Health Sciences
Record details
- Record id
cardio:ct-nct05257564- Content hash
9eb0a0524a529344d5a1eb36760e4258ae207c23934149eeb05e098664594a22